NOF Seeking Effective & Exceptional Successor »

| NOF in the News

The National Osteoporosis Foundation (NOF) is the leading health organization dedicated to preventing osteoporosis and broken bones, promoting strong bones for life and reducing human suffering through programs of public and clinician awareness, education, advocacy and research. Its highly respected Executive Director/CEO is retiring after eight years and NOF seeks an exceptional, charismatic and effective… Read more »

New National Survey Reveals 82 Percent of Postmenopausal Women Miss Critical Connection Between Osteoporosis and Bone Fractures »

| NOF in the News, Osteoporosis in the News, Press Releases

Joint Survey from National Osteoporosis Foundation, HealthyWomen and Radius Health Sounds an Urgent Call to Action for Women to Know Their Risk, Get the Facts: ‘Fractured Truth’ Education Campaign Addresses Entrenched Misperceptions, Asks Women to Rethink Their Beliefs About Bone Health WALTHAM, Mass., Aug. 10, 2017 (GLOBE NEWSWIRE) — A fracture (bone break) in a… Read more »

Don’t Fall For A Fractured Truth »

| NOF in the News, Osteoporosis in the News

NOF, HealthyWomen and Radius health recently launched a new education campaign called “Fractured Truth”. This initiative is intended to help postmenopausal women understand the connection between fractures and osteoporosis, the critical need to be proactive about their bone health, and to recognize the myths that are often associated with this disease. As part of the… Read more »

NOF Response to S. 1688 Bill »

| Advocacy, NOF in the News

The National Osteoporosis Foundation (NOF), which recently led a letter to Congress signed by over 300 health advocacy groups opposing harmful government interference in the Medicare Part D program, today issued the following statement in response to S. 1688: “It is discouraging that, despite direct opposition from over 300 health advocates, members of Congress have… Read more »

NOF Response to Newly Released Evidence Report on Cost Effectiveness of Anabolic Therapies for Osteoporosis in Postmenopausal Women from the Institute for Clinical and Economic Review (ICER) »

| NOF in the News, Press Releases

The Institute for Clinical and Economic Review (ICER) recently issued a Final Evidence Report accessing the comparative clinical effectiveness and value of anabolic agents for the treatment of osteoporosis in postmenopausal women, including teriparatide and abaloparatide.  NOF leadership and colleagues representing the National Bone Health Alliance (NBHA) provided input and shared ideas and potential concerns… Read more »

The Cost of Prescription Drugs: How the Drug Delivery System Affects What Patients Pay »

| Advocacy, NOF in the News, Press Releases

Washington, DC (June 13, 2017) – The National Osteoporosis Foundation (NOF), today issued the following statement in response to the Senate HELP hearing “The Cost of Prescription Drugs: How the Drug Delivery System Affects What Patients Pay” “During today’s hearing, several Senators raised the idea of allowing for the government to set prices in the… Read more »

Osteoporosis: ACP update treatment guidelines for preventing bone fractures »

| NOF in the News, Osteoporosis in the News

To reduce the risk of hip and vertebral fractures in women with osteoporosis, physicians should treat them with the bisphosphonates risedronate, alendronate, or zoledronic acid, or alternatively with the biologic agent denosumab. This strong recommendation appears in revised guidelines from the American College of Physicians (ACP) for the prevention of fractures in men and women… Read more »

The NOF’s Methods and Processes for Developing Position Statements »

| NOF in the News, Osteoporosis in the News, Press Releases

The National Osteoporosis Foundation frequently publishes position statements for the benefit of educating healthcare professionals and the general public on a particular issue and/or concern related to preventing osteoporosis and/or promoting strong bones throughout the lifespan. This manuscript represents the official methods and processes adopted by the NOF Board of Trustees for the purpose developing… Read more »

CMS Proposes New Fee Schedules for 2017 »

| NOF in the News, Osteoporosis in the News

On July 14, 2016, the Centers for Medicare and Medicaid Services (CMS) published the proposed rule for the Hospital Outpatient Prospective Payment System  (HOPPS) for 2017. CMS has proposed to cut the reimbursement rate for Axial DXA, CPT 77080 in the hospital setting from the current national average of $100.69 to $63.33. This reimbursement cut will… Read more »